PATENT CLAIM ANALYSIS

Application Number: 16247170
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-08
Patent Classification: ["514", "249000"]

Abstract:
The present invention relates to compounds of the formula (I), or pharmaceutically acceptable salts, enantiomer or diastereomer thereof, wherein R 1  to R 4  and Q are as described above. The compounds may be useful for the treatment or prophylaxis of hepatitis B virus infection.

Claim (Index 11):
A pharmaceutical composition comprising a compound in accordance with  claim 1  and a therapeutically inert carrier.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 99.0
- Lexical Diversity: 1.26829
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14997346', '16196324', '16247084', '11208962', '11413872']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8035650086078692
- 35 USC 102 Novelty (BERT): 0.5902834586357398
- Combined Prediction Score: 0.7822368536106562
- Mean Citation Score: 411.434974
- Max Citation Score: 512.69696
- Similarity Product: 454.3676671875

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test